Molecular genetic aspects of the development of atopic dermatitis

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Atopic dermatitis (AD) is one of the most common dermatoses in the world. It significantly reduces the quality of life of patients, and is a significant social and economic problem. Although the pathogenesis of AD is currently not fully understood, it is complex and appears to be the result of a combination of genetic and environmental factors that cause a defect in the epidermal barrier, an altered immune response, and an imbalance in the microbial balance of the skin. The study of the pathogenetic mechanisms of AD, the identification of its new components is an urgent problem due to the steady increase in the prevalence of the disease and can improve the efficiency of its diagnosis and treatment. The article presents a review of domestic and foreign literature sources devoted to the study of the most significant pathogenetic factors of AD.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Anna Sysoeva

Penza Institute for Postgraduate Medical Education – Branch Campus of RMACPE

Хат алмасуға жауапты Автор.
Email: sysojchik@yandex.ru
ORCID iD: 0009-0008-6981-464X
SPIN-код: 1026-7270

Teaching Assistant atof the Department of Medical Microbiology and Laboratory Medicine

Ресей, Penza

E. Orlova

Penza Institute for Postgraduate Medical Education – Branch Campus of RMACPE

Email: sysojchik@yandex.ru
ORCID iD: 0000-0002-3902-2018
Ресей, Penza

О. Levashova

Penza Institute for Postgraduate Medical Education – Branch Campus of RMACPE

Email: sysojchik@yandex.ru
ORCID iD: 0000-0002-8440-6598
Ресей, Penza

A. Turovskaya

Penza Institute for Postgraduate Medical Education – Branch Campus of RMACPE

Email: sysojchik@yandex.ru
ORCID iD: 0000-0002-5138-808X
Ресей, Penza

L. Iskanderova

Penza Regional Children’s Clinical Hospital n.a. N.F. Filatov

Email: sysojchik@yandex.ru
ORCID iD: 0009-0005-7888-1156
Ресей, Penza

A. Kozina

Penza Institute for Postgraduate Medical Education – Branch Campus of RMACPE

Email: sysojchik@yandex.ru
ORCID iD: 0009-0007-4931-8115
Ресей, Penza

E. Kostina

Penza Institute for Postgraduate Medical Education – Branch Campus of RMACPE

Email: sysojchik@yandex.ru
ORCID iD: 0000-0003-1797-8040
Ресей, Penza

Әдебиет тізімі

  1. Потекаев Н.Н., Серов Д.Н., Михайлова И.А. и др. Современные аспекты патогенеза и терапии атопического дерматита. Клиническая дерматология и венерология. 2019;18(3):259–63. [Potekaev N.N., Serov D.N., Mikhailova I.A., et al. Current aspects of pathogenesis and treatment of atopic dermatitis. Klinicheskaya dermatologiya i venerologiya. 2019;18(3):259–63. (In Russ.)]. doi: 10.17116/klinderma20191803125.
  2. Frazier W., Bhardwaj N. Atopic Dermatitis: Diagnosis and Treatment. Am Fam Physician. 2020;101(10):590–98.
  3. Strom M.A., Silverberg J.I. Utilization of Preventive Health Care in Adults and Children With Eczema. Am J Prev Med. 2016;50(2):e33–44. doi: 10.1016/j.amepre.2015.07.029.
  4. Silverberg J.I., Simpson E.L. Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization. Pediatr Allergy Immunol. 2013;24(5):476–86. doi: 10.1111/pai.12095.
  5. Serrano L., Patel K.R., Silverberg J.I. Association between atopic dermatitis and extracutaneous bacterial and mycobacterial infections: A systematic review and meta-analysis. J Am Acad Dermatol. 2019; 80(4): 904–12. doi: 10.1016/j.jaad.2018.11.028.
  6. Крысанов И.С., Крысанова В.С., Карпов О.И. и др. Экономическое бремя тяжелого атопического дерматита в Российской Федерации. Качественная клиническая практика. 2019;(4):4–14. [Krysanov I.S., Krysanova V.S., et al. Social-economic burden of severe atopic dermatitis in the Russian Federation. Kachestvennaya klinicheskaya praktika. 2019;(4):4–14. (In Russ.)].
  7. Горский В.С., Блюмина В.А. Современные представления о патогенезе атопического дерматита. Иммунопатология, аллергология, инфектология. 2022;(30):77–6. [Gorsky V.S., Blyumina V.A. Modern concepts of pathogenesis of atopic dermatitis. Immunopatologiya, allergologiya, infektologiya. 2022;(30):77–6. (In Russ.)]. Doi: 10.14427/ jipai.2022.3.70.
  8. Кубанова А.А., Кубанов А.А., Карамова А.Э. и др. Перспективные направления в терапии атопического дерматита. 2017;5:32–44. doi: 10.25208/0042-4609- 017-93-5-34-46. [Kubanova A.A., Kubanov A. A., Karamova A. E., et al. Biological therapeutic treatment of atopic dermatitis. Vestnik dermatologii i venerologii. 2017;5:32–44. (In Russ.)]. Вестник дерматологии и венерологии.
  9. Torres T., Ferreira E.O., Goncalo M., et al. Update on Atopic Dermatitis. Acta Med Port. 2019;32(9):606–13. doi: 10.20344/amp.11963.
  10. Al-Afif K.A.M., Buraik M.A., Buddenkotte J., et al. Understanding the Burden of Atopic Dermatitis in Africa and the Middle East. Dermatol Ther (Heidelb). 2019;9(2):223–41. doi: 10.1007/s13555-019-0285-2.
  11. Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol. 1993;28(5 Pt. 1):719–23. doi: 10.1016/0190-9622(93)70099-f.
  12. Nedoszytko B., Reszka E., Gutowska-Owsiak D., et al. Genetic and Epigenetic Aspects of Atopic Dermatitis. Int J Mol Sci. 2020;21(18):6484. doi: 10.3390/ijms21186484.
  13. Sroka-Tomaszewska J., Trzeciak M. Molecular Mechanisms of Atopic Dermatitis Pathogenesis. Int J Mol Sci. 2021;22(8):4130. doi: 10.3390/ijms22084130.
  14. South A.P., Cabral A., Ives J.H., et al. Human epidermal differentiation complex in a single 2.5 Mbp long continuum of overlapping DNA cloned in bacteria integrating physical and transcript maps. J Investig Dermatol. 1999;112:910–18. doi: 10.1046/j.1523-1747. 1999.00613.x.
  15. Weidinger S., Illig T., Baurecht H., et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol. 2006;118:214–12. doi: 10.1016/j.jaci.2006.05.004.
  16. Moosbrugger-Martinz V., Leprince C., Mechin M.C., et al. Revisiting the Roles of Filaggrin in Atopic Dermatit. Int J Mol Sci. 2022;23(10):5318. doi: 10.3390/ijms23105318.
  17. Cepelak I., Dodig S., Pavic I. Filaggrin and atopic march. Biochem Med. 2019;29:020501. doi: 10.11613/BM.2019.020501.
  18. Tsuji G., Hashimoto-Hachiya A., Kiyomatsu-Oda M., et al. Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis. Cell Death Dis. 2017;8:e2931. doi: 10.1038/cddis.2017.322.
  19. Furue M. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis. Int J Mol Sci. 2020;21(15):5382. doi: 10.3390/ijms21155382.
  20. Lee A.Y. Molecular Mechanism of Epidermal Barrier Dysfunction as Primary Abnormalities. Int J Mol Sci. 2020;21(4):1194. doi: 10.3390/ijms21041194.
  21. Sevilla L.M., Nachat R., Groot K.R., et al. Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier. J Cell Biol. 2007;179.(7):1599–612. doi: 10.1083/jcb.200706187.
  22. Xia Y., Cao H., Zheng J., et al. Claudin-1 Mediated Tight Junction Dysfunction as a Contributor to Atopic March. Front Immunol. 2022;13:927465. Doi: 10.3389 / fimmu.2022.927465.
  23. Mu Z., Zhang J. The Role of Genetics, the Environment, and Epigenetics in Atopic Dermatitis. Adv Exp Med Biol. 2020;1253:107–40. doi: 10.1007/978-981-15-3449-2_4.
  24. Martin M.J., Estravis M., Garcia-Sanchez A., et al. Genetics and Epigenetics of Atopic Dermatitis: An Updated Systematic Review. Genes (Basel). 2020;11(4):442. doi: 10.3390/genes11040442.
  25. Rodriguez E., Baurecht H., Wahn A.F., et al. An integrated epigenetic and transcriptomic analysis reveals distinct tissue-specific patterns of DNA methylation associated with atopic dermatitis. J Invest Dermatol. 2014;134:1873–83. doi: 10.1038/jid.2014.87.
  26. Hato T., Dagher P.C. How the Innate Immune System Senses Trouble and Causes Trouble. Clin. J Am Soc Nephrol. 2015;10:1459–69. doi: 10.2215/CJN.04680514.
  27. Kuo I.H., Carpenter-Mendini A., Yoshida T., et al. Activation of epidermal toll-like receptor 2 enhances tight junction function: Implications for atopic dermatitis and skin barrier repair. J Invest Dermatol. 2013;133:988–98. doi: 10.1038/jid.2012.437.
  28. Li H., Zhang Z., Zhang H., et al. Update on the Pathogenesis and Therapy of Atopic Dermatitis. Clin Rev Allergy Immunol. 2021;61(3):324–38. doi: 10.1007/s12016-021-08880-3.
  29. Makowska K., Nowaczyk J., Blicharz L., et al. Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments. Int J Mol Sci. 2023;24(1):781. Doi: 10.3390/ ijms24010781.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2023

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>